$AMGN News and Market Events
Every $AMGN story Market Flux has tracked.
- Market Flux Event
S&P 500 and Nasdaq Slide After September CPI Tops Estimates and BofA Posts $1.2B Charge
Wall Street fell Wednesday after September's Consumer Price Index came in hotter than expected, reigniting concerns about Federal Reserve rate policy. The CPI rose 3.7% year over year…
- Top Mover
Amgen's Dazodalibep Hits Phase 3 Primary Endpoint in Sjogrens Disease Trial
Amgen reported positive top-line results from its Phase 3 OASIZ 301 trial of dazodalibep in patients with moderate-to-severe systemic Sjogren's disease, a chronic autoimmune condition that…
- Unusual Volume
HSBC CFO Pam Kaur to Leave in 2027 as Bank Begins Successor Search
HSBC's Chief Financial Officer Pam Kaur has informed the bank's board of her intention to step down in 2027, triggering an immediate search for her replacement. Kaur, who is HSBC's first…
- Unusual Volume
Novartis Shares Crash 14% to 52-Week Low After Three Drug Trial Failures in One Week
Novartis suffered a devastating session on Tuesday, September 8, with its U.S.-listed shares tumbling roughly 14% to close at $137.70, a fresh 52-week low, after two major late-stage…
- Top Mover
Amgen Plunges 10% as Novartis Lp(a) Trial Failure Casts Doubt on Olpasiran Program
Amgen shares fell roughly 10% on Tuesday, putting the stock on course for its worst single-day decline since 2000, after Novartis reported that its Lp(a)-lowering drug pelacarsen failed in…
- Market Flux Event
Trump Announces Drug Pricing Deals With Nine More Pharma Companies, Expanding Most Favored Nation Push
President Trump announced on August 31 that his administration has struck drug pricing agreements with nine additional pharmaceutical and biotech companies, committing them to sell…
- Market Flux Event
FDA Expands Mounjaro Label to Reduce Heart Attack and Stroke Risk in Type 2 Diabetes Patients
The FDA approved an expanded label for Eli Lilly's Mounjaro (tirzepatide) to reduce major adverse cardiovascular events, including heart attack and stroke, in high-risk patients with type 2…